Matthew Gaskill, DO
Clinical Cardiac Electrophysiology · Morgantown, WVNPI 1467716159
Payments from drug & device makers
What this record shows
26 manufacturers reported payments, led by Abbott at 57.7% of the total. Reporting peaked in 2023 at $5,272 and has fallen 61.0% since, to $2,055 in 2025.
Across 299 payments — averaging $48.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$8K
- Boston Scientific$3K
- Siemens Medical Solutions USA, Inc.$680
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$604
- E.r. Squibb & Sons, L.L.C.$276
- Novartis$179
- plus $1K from 20 others
What the payments were for
- Travel & lodging$6,31444%
- Food & beverage$8,11756%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 81 | $8,329 |
| Boston Scientific | 106 | $3,050 |
| Siemens Medical Solutions USA, Inc. | 11 | $680 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 36 | $604 |
| E.r. Squibb & Sons, L.L.C. | 13 | $276 |
| Novartis | 11 | $179 |
| Philips North America LLC | 4 | $166 |
| AstraZeneca | 4 | $144 |
| Heartflow, Inc. | 1 | $136 |
| Impulse Dynamics (USA) Inc. | 3 | $113 |
| Janssen Scientific Affairs, LLC | 1 | $101 |
| Kestra Medical Technology Services, Inc. | 3 | $98 |
| Johnson & Johnson | 2 | $98 |
| Recor Medical Inc | 3 | $66 |
| Pfizer | 3 | $54 |
| Sanofi-aventis U.S. LLC | 3 | $53 |
| Medtronic | 1 | $46 |
| Amgen | 3 | $45 |
| Atricure, Inc. | 1 | $45 |
| Merck | 2 | $35 |
| Abiomed | 1 | $32 |
| Boehringer Ingelheim | 2 | $30 |
| Bayer | 1 | $17 |
| Regeneron Healthcare Solutions, Inc. | 1 | $17 |
| Elutia, Inc. | 1 | $10 |
| Altathera Pharmaceuticals LLC | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AVEIR$4,463
- Allure CRT Pacemaker$1,418
- Watchman$354
- ARTIS icono biplane$304
- Artis Q.zen biplane$304
- EnSite Precision Cardiac Mapping System$227
- GENERAL - THERAPIES$169
- JOT DX$148
- WATCHMAN FLX$142
- FFRct$136
- Allure Quadra RF CRT Pacemaker$122
- CARDIOMEMS$118
- Rhythmia Mapping System$113
- SQ RX PULSE GENERATOR$112
- MitraClip$110
- ACUSON SC2000 Diagnostic Ultrasound System$108
- (5044) MCOT$103
- XARELTO$101
How this compares
Too few clinical cardiac electrophysiology providers in West Virginiato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 272 | $333,654 |
| EntrestoSacubitril/Valsartan | 27 | $34,023 |
| XareltoRivaroxaban | 20 | $33,036 |
| Metoprolol Succinate | 248 | $3,540 |
| Flecainide Acetate | 51 | $2,647 |
| Amiodarone Hcl | 117 | $1,975 |
| Dofetilide | 12 | $1,783 |
| Digoxin | 35 | $895 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 29 | $862 |
| Midodrine Hcl | 16 | $729 |
| Warfarin Sodium | 60 | $610 |
| SotalolSotalol Hcl | 16 | $430 |
| Metoprolol Tartrate | 16 | $131 |
| Carvedilol | 14 | $79 |
| Amlodipine Besylate | 16 | $45 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $54 | $333,654272 claims |
| NovartisEntresto | $179 | $34,02327 claims |
| Johnson & JohnsonXarelto | $98 | $33,03620 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few clinical cardiac electrophysiology providers in West Virginiaon file to place this against a meaningful peer group, so we don't.
Other clinical cardiac electrophysiology in Morgantown
- Salam SbaityMorgantown$50K
- Latoya Linton-FrazierMorgantown$36K
- Alexey SergeevMorgantown$15K
- Suppiramaniam SreeharikesanMorgantown$14K
- Kenneth JudsonMorgantown$7K
- Stanley SchmidtMorgantown$4K
- Robert HullMorgantown$4K
- George JosephWeirton$97K
- Chafik AssalCharleston$84K
- Khalid AbozguiaHuntington$73K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.